NEUROBO PHARMACEUTICALS INC (NRBO) Stock Cash Flow
USA - NASDAQ:NRBO - US64132R4048 - Common Stock
2.36 USD
+0.01 (+0.43%)
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -27.73M | -12.47M | -13.97M | -15.28M | -29.68M | |||
| Depreciation Amortization | 21.00K | 6.00K | 20.00K | 50.00K | 50.00K | |||
| Change In Working Capital | 4.71M | 4.40M | -1.17M | -580.00K | 810.00K | |||
| Interest Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Taxes Paid | N/A | N/A | N/A | N/A | 0.00 | |||
| Other non cash items | 326.00K | -2.73M | 3.40M | 690.00K | 18.06M | |||
| OPERATING CASH FLOW | -22.67M | -10.80M | -11.71M | -15.13M | -10.76M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -18.00K | -50.00K | 0.00 | 0.00 | 0.00 | |||
| Other Investing Activity | N/A | N/A | 10.00K | -580.00K | 70.00K | |||
| INVESTING CASH FLOW | -18.00K | -50.00K | 10.00K | -590.00K | 70.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | N/A | |||
| Stock Issued/Repurchased | N/A | 0.00 | 32.25M | 24.12M | 7.55M | |||
| Other Financing Activity | -1.47M | -80.00K | -3.57M | -2.09M | -700.00K | |||
| FINANCING CASH FLOW | 18.52M | -80.00K | 28.68M | 22.03M | 6.86M | |||
| Exchange Rate Effect | N/A | N/A | 0.00 | -10.00K | 0.00 | |||
| CHANGE IN CASH | -4.16M | -10.93M | 16.98M | 6.30M | -3.83M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -22.67M | -10.80M | -11.71M | -15.13M | -10.76M | |||
| Capital Expenditure | -18.00K | -50.00K | 0.00 | 0.00 | 0.00 | |||
| FREE CASH FLOW | -22.69M | -10.85M | -11.71M | -15.13M | -10.76M | |||
All data in USD